title: Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
authors.forename: M
authors.initials: M
authors.lastname: Boran
authors.forename: I
authors.initials: I
authors.lastname: Dalva
authors.forename: F
authors.initials: F
authors.lastname: Gönenç
authors.forename: S
authors.initials: S
authors.lastname: Cetin
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002331:Carnitine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D002331:Carnitine